QuickView for axon midline choice point recognition (biogroup)

1. NSCLC PC9 cells selected for gefitinib sensitivity or resistance treated with EGF and gefitinib
2. Autosomal dosage compensation in Drosophila DrosDel deficiency lines
3. Blastula diploid and haploid Drosophila embryos at cycle 13 and 14 interphase
4. Drosophila melanogaster gene expression in response to overexpression of human PON1
5. Gene profiling of the reversion of post-implantation epiblast cells

There were no matches for axon midline choice point recognition

There were no clinical trials for axon midline choice point recognition